AstraZeneca Pharma India Ltd — Quarterly Results & Earnings

₹7931.00

-5.75%

Profit Growth YoY51.26%Latest quarter

Sales Growth YoY37.03%Latest quarter

Sales CAGR 5Y15.59%5 year compound

Profit CAGR 5Y19.45%5 year compound

📋

Quarterly Performance

YoY Profit Growth+51.26%

🔥 Exceptional growth

YoY Sales Growth+37.03%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

14.65%

EPS Growth 5Y

19.45%

Interest Coverage

Higher = safer debt servicing

131.37

ROE

23.63%

ROCE

33.40%

💡

Growth Analysis

AstraZeneca Pharma India Ltd reported YoY profit growth of 51.26% and revenue growth of 37.03% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 15.59% and profits at 19.45% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on AstraZeneca Pharma India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.